Skip to main content

Table 2 Baseline vital parameters and laboratory results of 13 HIV-positive participants and 12 HIV-positive persons of the Reference group

From: Moderate endurance training (marathon-training) – effects on immunologic and metabolic parameters in HIV-infected patients: the 42 KM cologne project

Parameter Participants (Baseline) Reference Group p (Participants vs. Reference group)
CD4-count (/μl) 620 [146–1268] 571 [230–955] 0.81
Annexin-binding (% of CD4+ cells) 53 [47–64] 51 [46–52] 0.12
Sodium (mmol/l) 139 [136–142] 139 [132–141] 0.58
Phosphate (mmol/l) 1.06 [0.86–1.20] 0.91 [0.66–1.19] 0.03
Weight (kg) 78 [58–100] 77 [59–88] 0.44
Height (cm) 174 [158–182] 179 [168–185]  
RRsys (mmHg) 125 [100–145] 115 [100–130] 0.06
RRdia (mmHg) 80 [70–90] 70 [60–90] 0.08
Leukocytes (G/l) 6.1 [4.1–9.5] 6.3 [3.8–10.6] 0.80
Hemoglobin (g/dl) 15.9 [11.3–17.3] 14.6 [12.9–16.2] 0.38
Thrombocytes (G/l) 225 [171–294] 255 [147–342] 0.50
INR 1 [0.9–1.2] 1 [0.9–1.1] 0.06
Potassium (mmol/l) 3.9 [3.6–4.5] 4.3 [4.0–4.9] 0.001
Creatinine (mg/dl) 1.05 [0.8–1.17] 0.96 [0.74–1.16] 0.31
Triglycerides (mg/dl) 156 [85–328] 141 [67–326] 0.95
Cholesterol (mg/dl) 185 [98–250] 177 [111–302] 0.98
HDL-cholesterol (mg/dl) 48 [31–60] 40 [28–54] 0.28
LDL-cholesterol (mg/dl) 115 [45–161] 111 [61–198] 0.81
Insulin (mIU/l) 4.4 [2.1–9.5] 6 [2–35] 0.15
Glucose (mg/dl) 86 [78–107] 91 [83–100] 0.17
Bilirubin (mg/dl) 0.56 [0.28–2.90] 0.47 [0.26–2.90] 0.70
ALT (U/l) 25 [10–126] 23 [10–53] 0.42
Creatine kinase (U/l) 105 [66–145] 86 [55–155] 0.64
\